ArticleOPEN ACCESS

Correction: Angiosarcoma patients treated with immune checkpoint inhibitors: A case series of seven patients from a single institution (Journal for ImmunoTherapy of Cancer DOI: 10.1186/s40425-019-0689-7)

Journal for ImmunoTherapy of Cancer
DOI: 10.1186/s40425-019-0792-9
2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Following publication of the original article [1], the authors have reported that the following sentence "While of the same IgG1 class as ipilimumab, preclinical data suggests this molecule may have enhanced activity against T regulatory cells".

Cite

CITATION STYLE

APA

Florou, V., Rosenberg, A. E., Wieder, E., Komanduri, K. V., Kolonias, D., Uduman, M., … Wilky, B. A. (2019, November 6). Correction: Angiosarcoma patients treated with immune checkpoint inhibitors: A case series of seven patients from a single institution (Journal for ImmunoTherapy of Cancer DOI: 10.1186/s40425-019-0689-7). Journal for ImmunoTherapy of Cancer. BioMed Central Ltd. https://doi.org/10.1186/s40425-019-0792-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free